OTLKW

Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW

Overview Fund Activity
Delisted

OTLKW was delisted on the 16th of February, 2022.

Back to rankings

4 hedge funds and large institutions have $663K invested in Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
$282K
Puts
–
Net Calls
+$282K
Net Calls Change
+$119K

Top Buyers

1
CAM
Cormorant Asset Management
Massachusetts
+$421K

Top Sellers

1
PA
Perceptive Advisors
New York
-$93K
Name Holding Trade Value Shares
Change 		Shares
Change %
CAM
1
Cormorant Asset Management
Massachusetts
$421K +$421K +416,666 New
SFM
2
Sphera Funds Management
Israel
$131K – – –
PC
3
PointState Capital
New York
$101K – – –
CIA
4
Compass Ion Advisors
Pennsylvania
$10K – – –
PA
5
Perceptive Advisors
New York
– -$93K -420,875 Closed